Versant Venture Management, LLC - APREA THERAPEUTICS INC ownership

APREA THERAPEUTICS INC's ticker is APRE and the CUSIP is 03836J102. A total of 43 filers reported holding APREA THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.80 and the average weighting 0.0%.

Quarter-by-quarter ownership
Versant Venture Management, LLC ownership history of APREA THERAPEUTICS INC
ValueSharesWeighting
Q3 2021$6,437,000
+4.7%
1,259,6620.0%2.66%
+30.8%
Q2 2021$6,147,000
-4.3%
1,259,6620.0%2.04%
+62.7%
Q1 2021$6,424,000
-8.5%
1,259,662
-11.7%
1.25%
+71.7%
Q4 2020$7,018,000
-84.3%
1,426,328
-23.1%
0.73%
-91.1%
Q3 2020$44,613,000
-99.9%
1,854,2290.0%8.16%
-21.0%
Q2 2020$71,907,001,0001,854,22910.33%
Other shareholders
APREA THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
5AM Venture Management, LLC 2,212,654$85,807,00018.79%
Versant Venture Management, LLC 1,854,229$71,907,001,00010.33%
SECTORAL ASSET MANAGEMENT INC 915,681$35,510,0003.26%
Consonance Capital Management LP 1,252,185$48,560,0002.91%
Redmile Group, LLC 2,268,718$87,981,0001.62%
SPHERA FUNDS MANAGEMENT LTD. 158,289$6,138,0000.58%
Rock Springs Capital Management LP 518,290$20,099,0000.55%
Parkman Healthcare Partners LLC 40,036$1,553,0000.44%
Virtus ETF Advisers LLC 11,435$443,0000.21%
KENNEDY CAPITAL MANAGEMENT LLC 131,414$5,096,0000.15%
View complete list of APREA THERAPEUTICS INC shareholders